default author photo

Albiruni R. Abdul Razak

University of Toronto - Princess Margaret Cancer Centre

SCHOLARLY PAPERS

2

DOWNLOADS

78

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

A Phase Ii, Open-Label, Randomized Trial of Durvalumab with Olaparib or Cediranib in Patients with Mismatch Repair–Proficient Colorectal or Pancreatic Cancer

Number of pages: 54 Posted: 14 Mar 2024
Vall d’Hebron Institute of Oncology (VHIO), University of Toronto - Princess Margaret Cancer Centre, University of Toronto - Princess Margaret Cancer Centre, University of Toronto - Princess Margaret Cancer Centre, University of Toronto - Princess Margaret Cancer Centre, Vall d’Hebron Institute of Oncology (VHIO), University of Toronto - Princess Margaret Cancer Centre, University of Toronto - Princess Margaret Cancer Centre, University Health Network - Princess Margaret Cancer Centre, Vall d’Hebron Institute of Oncology (VHIO), Ontario Institute for Cancer Research, Ontario Institute for Cancer Research, University of Toronto - Princess Margaret Cancer Centre, University of Toronto - Princess Margaret Cancer Centre, University Health Network - Princess Margaret Bioinformatics and Computational Genomics Laboratory, Vall d’Hebron Institute of Oncology (VHIO), University of Toronto - Princess Margaret Cancer Centre, University of Toronto - Princess Margaret Cancer Centre, University Health Network - Tumor Immunotherapy Program, University of Toronto - Princess Margaret Cancer Centre, University of Toronto - Princess Margaret Cancer Centre and University of Toronto - Princess Margaret Cancer Centre
Downloads 43 (1,157,785)

Abstract:

Loading...

Immunotherapy, biomarkers, colorectal, pancreatic, cancer, cold tumors

2.

Real-Word Experience of Pazopanib and Sorafenib in Patients with Desmoid Tumors: A Cansarcc Multi-Center Study

Number of pages: 25 Posted: 20 Apr 2024
affiliation not provided to SSRN, Princess Margaret Hospital, BC Cancer - Vancouver, McGill University - McGill University Health Centre, affiliation not provided to SSRN, Centre Hospitalier Universitaire de Québec, Princess Margaret Hospital, McGill University - McGill University Health Centre, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Toronto - Princess Margaret Cancer Centre and affiliation not provided to SSRN
Downloads 35 (1,249,711)

Abstract:

Loading...

Desmoid tumor, sorafenib, pazopanib, targeted therapy, treatment discontinuation, outcomes